Table of Contents

2019-2024 Global Breast Cancer Diagnostic Technologies Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Breast Cancer Diagnostic Technologies Market Size 2014-2024
  • 2.1.2 Breast Cancer Diagnostic Technologies Market Size CAGR by Region
• 2.2 Breast Cancer Diagnostic Technologies Segment by Type
  • 2.2.1 Mammography
  • 2.2.2 Biopsy
  • 2.2.3 Companion Diagnostics
• 2.3 Breast Cancer Diagnostic Technologies Market Size by Type
  • 2.3.1 Global Breast Cancer Diagnostic Technologies Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Breast Cancer Diagnostic Technologies Market Size Growth Rate by Type (2014-2019)
• 2.4 Breast Cancer Diagnostic Technologies Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Others
• 2.5 Breast Cancer Diagnostic Technologies Market Size by Application
  • 2.5.1 Global Breast Cancer Diagnostic Technologies Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Breast Cancer Diagnostic Technologies Market Size Growth Rate by Application (2014-2019)

3 Global Breast Cancer Diagnostic Technologies by Players

• 3.1 Global Breast Cancer Diagnostic Technologies Market Size Market Share by Players
  • 3.1.1 Global Breast Cancer Diagnostic Technologies Market Size by Players (2017-2019)
  • 3.1.2 Global Breast Cancer Diagnostic Technologies Market Size Market Share by Players (2017-2019)
• 3.2 Global Breast Cancer Diagnostic Technologies Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Breast Cancer Diagnostic Technologies by Regions

• 4.1 Breast Cancer Diagnostic Technologies Market Size by Regions
• 4.2 Americas Breast Cancer Diagnostic Technologies Market Size Growth
• 4.3 APAC Breast Cancer Diagnostic Technologies Market Size Growth
• 4.4 Europe Breast Cancer Diagnostic Technologies Market Size Growth
• 4.5 Middle East & Africa Breast Cancer Diagnostic Technologies Market Size Growth

5 Americas

• 5.1 Americas Breast Cancer Diagnostic Technologies Market Size by Countries
• 5.2 Americas Breast Cancer Diagnostic Technologies Market Size by Type
• 5.3 Americas Breast Cancer Diagnostic Technologies Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Breast Cancer Diagnostic Technologies Market Size by Countries
• 6.2 APAC Breast Cancer Diagnostic Technologies Market Size by Type
• 6.3 APAC Breast Cancer Diagnostic Technologies Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Breast Cancer Diagnostic Technologies by Countries
• 7.2 Europe Breast Cancer Diagnostic Technologies Market Size by Type
• 7.3 Europe Breast Cancer Diagnostic Technologies Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Breast Cancer Diagnostic Technologies by Countries
• 8.2 Middle East & Africa Breast Cancer Diagnostic Technologies Market Size by Type
• 8.3 Middle East & Africa Breast Cancer Diagnostic Technologies Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Breast Cancer Diagnostic Technologies Market Forecast

• 10.1 Global Breast Cancer Diagnostic Technologies Market Size Forecast (2019-2024)
• 10.2 Global Breast Cancer Diagnostic Technologies Forecast by Regions
  • 10.2.1 Global Breast Cancer Diagnostic Technologies Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Breast Cancer Diagnostic Technologies Forecast by Type
• 10.8 Global Breast Cancer Diagnostic Technologies Forecast by Application

11 Key Players Analysis

• 11.1 Abbvie
  • 11.1.1 Company Details
  • 11.1.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.1.3 Abbvie Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Abbvie News
• 11.2 Abbott
  • 11.2.1 Company Details
  • 11.2.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.2.3 Abbott Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Abbott News
• 11.3 Bristol-Myers Squibb
  • 11.3.1 Company Details
  • 11.3.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.3.3 Bristol-Myers Squibb Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Bristol-Myers Squibb News
• 11.4 Agilent Technologies
  • 11.4.1 Company Details
  • 11.4.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.4.3 Agilent Technologies Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Agilent Technologies News
• 11.5 Novartis
  • 11.5.1 Company Details
  • 11.5.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.5.3 Novartis Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Novartis News
• 11.6 Pfizer
  • 11.6.1 Company Details
  • 11.6.2 Breast Cancer Diagnostic Technologies Product Offered
  • 11.6.3 Pfizer Breast Cancer Diagnostic Technologies Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Pfizer News

...

12 Research Findings and Conclusion

Breast cancer diagnosis and treatment are best accomplished by a team of experts working together with the patient.

According to this study, over the next five years the Breast Cancer Diagnostic Technologies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Breast Cancer Diagnostic Technologies business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Breast Cancer Diagnostic Technologies market by product type, application, key companies and key regions.

This study considers the Breast Cancer Diagnostic Technologies value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Mammography
Biopsy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbvie
Abbott
Bristol-Myers Squibb
Agilent Technologies
Novartis
Pfizer
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Breast Cancer Diagnostic Technologies market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Breast Cancer Diagnostic Technologies market by identifying its various subsegments.
Focuses on the key global Breast Cancer Diagnostic Technologies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Breast Cancer Diagnostic Technologies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Breast Cancer Diagnostic Technologies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.